<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochemistry</journal-id><journal-id journal-id-type="iso-abbrev">Biochemistry</journal-id><journal-id journal-id-type="publisher-id">bi</journal-id><journal-id journal-id-type="coden">bichaw</journal-id><journal-title-group><journal-title>Biochemistry</journal-title></journal-title-group><issn pub-type="ppub">0006-2960</issn><issn pub-type="epub">1520-4995</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7341687</article-id><article-id pub-id-type="doi">10.1021/acs.biochem.0c00309</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Molecular Basis for ADP-Ribose Binding to the Mac1 Domain of SARS-CoV-2
nsp3</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="ath1"><name><surname>Frick</surname><given-names>David N.</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Virdi</surname><given-names>Rajdeep S.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Vuksanovic</surname><given-names>Nemanja</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Dahal</surname><given-names>Narayan</given-names></name><xref rid="aff1" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" id="ath5"><name><surname>Silvaggi</surname><given-names>Nicholas R.</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><sup>&#x02020;</sup>Department of Chemistry &#x00026; Biochemistry and
<sup>&#x02021;</sup>Department of Physics, <institution>University of
Wisconsin&#x02014;Milwaukee</institution>, Milwaukee, Wisconsin 53217, <country>United
States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Department of Chemistry &#x00026; Biochemistry, University of
Wisconsin&#x02014;Milwaukee, 3210 N. Cramer St., Milwaukee, WI 53211. Email:
<email>frickd@uwm.edu</email>. Phone: <phone>(414) 251-7695</phone>. Fax: <fax>(414)
229-5530</fax>.</corresp></author-notes><pub-date pub-type="epub"><day>29</day><month>06</month><year>2020</year></pub-date><elocation-id>acs.biochem.0c00309</elocation-id><history><date date-type="received"><day>16</day><month>04</month><year>2020</year></date><date date-type="rev-recd"><day>22</day><month>06</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 American Chemical Society</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license license-type="open-access"><license-p>This article is made available via the PMC Open Access Subset for unrestricted RESEARCH
re-use and analyses in any form or by any means with acknowledgement of the original
source. These permissions are granted for the duration of the World Health Organization
(WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi0c00309_0005" id="ab-tgr1"/></p><p>The virus that causes COVID-19, SARS-CoV-2, has a large RNA genome that encodes
numerous proteins that might be targets for antiviral drugs. Some of these proteins,
such as the RNA-dependent RNA polymerase, helicase, and main protease, are well
conserved between SARS-CoV-2 and the original SARS virus, but several others are not.
This study examines one of the proteins encoded by SARS-CoV-2 that is most different, a
macrodomain of nonstructural protein 3 (nsp3). Although 26% of the amino acids in this
SARS-CoV-2 macrodomain differ from those observed in other coronaviruses, biochemical
and structural data reveal that the protein retains the ability to bind ADP-ribose,
which is an important characteristic of beta coronaviruses and a potential therapeutic
target.</p></abstract><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>bi0c00309</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>bi0c00309</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">The development of antivirals targeting severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the causative agent of the present COVID-19 pandemic,<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> will
most likely focus on viral proteins and enzymes needed for replication.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup>
Similar to other coronaviruses, SARS-CoV-2 has a large positive sense (+)RNA genome that is
more than 30000 nucleotides long with several open reading frames. Most of the proteins that
form the viral replicase are encoded by the &#x0201c;rep 1ab&#x0201d; reading frame, which
encodes a 7096-amino acid polyprotein that is ultimately processed into at least 15
functional peptides, five of which are produced only by a translational frameshift event
occurring after nsp10 (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>). Parts of the
SARS-CoV-2 rep 1ab polyprotein are very similar to the rep 1ab protein of the coronavirus
that caused the SARS epidemic in 2003 (which here will be termed SARS-CoV), suggesting the
that drugs targeting SARS-CoV nsp5&#x02013;14 might be effective against SARS-CoV-2. However,
some portions of the SARS rep 1ab polyproteins are quite different.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Sequence divergence between potential drug targets in SARS-CoV and SARS-CoV-2. The
SARS-CoV-2 rep 1ab peptide sequence was aligned with each of the PDB files listed, which
describe an atomic structure of a homologous region of the SARS-CoV rep 1ab polyprotein.
nsps are shown in sequence as black arrows (note that there is no &#x0201c;nsp11&#x0201d;,
and the translational frameshift occurs after nsp10). The percent of amino acids that
differ in each protein is plotted. nsp1 is an interferon antagonist.<sup><xref ref-type="bibr" rid="ref28">28</xref></sup> The nsp3 Mac1 domain is studied here. Mac2 and Mac3 are tandem macrodomains that bind
G-quadruplex structures,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> and nsp3 dC is the C-terminus of
Mac3.<sup><xref ref-type="bibr" rid="ref29">29</xref></sup> nsp3pro is a papain-like protease,<sup><xref ref-type="bibr" rid="ref30">30</xref></sup> and
nsp3 RBD is another possible RNA-binding domain.<sup><xref ref-type="bibr" rid="ref31">31</xref></sup> nsp5 is the main
viral protease.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> nsp7 and nsp8 are polymerase cofactors.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> nsp9 is an RNA-binding protein.<sup><xref ref-type="bibr" rid="ref34">34</xref></sup> nsp10 is a
zinc-binding cofactor for nsp14 and nsp16.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup> nsp12 is an RNA
polymerase.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> nsp13 is a helicase.<sup><xref ref-type="bibr" rid="ref36">36</xref></sup> nsp14 is a
3&#x02032;&#x02013;5&#x02032; exonuclease and a 7-methyltransferase.<sup><xref ref-type="bibr" rid="ref35">35</xref></sup>
nsp15 is an RNA endonuclease.<sup><xref ref-type="bibr" rid="ref37">37</xref></sup> nsp16 is an RNA cap
2&#x02032;-<italic>O</italic>-methyltransferase.<sup><xref ref-type="bibr" rid="ref38">38</xref></sup></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi0c00309_0001" id="gr1" position="float"/></fig><p>In contrast to the well-conserved SARS-CoV nsp5 protease, nsp12 polymerase, and nsp13
helicase enzymes, significantly more differences exist between the nsp3 proteins encoded by
SARS-CoV and SARS-CoV-2. The most variation occurs in a domain of nsp3 suspected to bind
ADP-ribose, which will here be termed the Mac1 domain,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> to differentiate
it from the two downstream macrodomains (Mac2 and Mac3), which do not bind
ADP-ribose.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> The Mac1 domain of SARS-CoV also catalyzes the hydrolysis
of ADP-ribose 1&#x02032;&#x02032; phosphate, albeit at a slow rate.<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> Some
viral macrodomains also remove ADP-ribose from proteins,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and this
de-ADP-ribosylation activity correlates with virulence and the ability to evade the innate
immune response.<sup><xref ref-type="bibr" rid="ref6">6</xref>&#x02212;<xref ref-type="bibr" rid="ref11">11</xref></sup> Jean-Michel Claverie recently suggested that the putative
ability of Mac1 to remove ADP-ribose from proteins might be related to the cytokine storm
syndrome seen in severe cases of COVID-19.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup></p><p>Compounds blocking ADP-ribose binding could be used to test this important hypothesis.
However, the many sequence differences preclude the use of the SARS-CoV Mac1 domain
structures as scaffolds to design compounds that might target this nsp3 region in
SARS-CoV-2. ADP-ribose binding must also be confirmed, especially in light of the
observation that the same nsp3 domain from gamma coronaviruses does not bind ADP-ribose
<italic>in vitro</italic>.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> The ability of the SARS-CoV-2 Mac1 domain
to bind ADP-ribose was therefore examined here using a recombinant purified protein and
isothermal titration calorimetry (ITC). We also determined the structure of the SARS-CoV-2
Mac1 domain to examine the biochemical context of ADP-ribose binding and to provide data for
rational inhibitor design or <italic>in silico</italic> screening.</p><sec id="sec2"><title>Materials and Methods</title><sec id="sec2.1"><title>Gene Synthesis</title><p>To facilitate the comparison between SARS-CoV and SARS-CoV-2, a protein expression vector
was generated that is similar to that used by Eglott et al.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> To this
end, a codon-optimized open reading frame was synthesized by GenScript (Piscataway, NJ)
that encodes the Mac1 domain with an N-terminal TEV-cleavage site flanked by
<italic>Nhe</italic>I and <italic>Bam</italic>HI restriction sites. This open reading
frame was cloned into pET21b to yield plasmid pET21-COVID-Mac1. The pET11-COVID-Mac1
plasmid was used to transform BL21(DE3) cells.</p></sec><sec id="sec2.2"><title>Protein Purification</title><p>Colonies of BL21(DE3) cells harboring the pET21-COVID-Mac1 plasmid were used to inoculate
3 mL of lysogeny broth containing 100 mg/mL ampicillin. The starter culture was incubated
at 37 &#x000b0;C while being shaken at 225 rpm. After the cells grew to an OD<sub>600</sub>
of 1.0, they were transferred to 1 L of fresh medium containing ampicillin. After the
cells reached an OD<sub>600</sub> of 1.0 again, protein production was induced with 1 mM
isopropyl &#x003b2;-<sc>d</sc>-thiogalactoside. After growing for 16 h at 23 &#x000b0;C, cells
were harvested by centrifugation at 4000 rpm and 4 &#x000b0;C. The resulting cell pellet was
suspended in 25 mL of IMAC buffer [20 mM Tris (pH 8) and 0.5 M NaCl], sonicated on ice for
five 1 min bursts separated by 2 min rests, and clarified by centrifugation at
10000<italic>g</italic> for 30 min. The supernatant was loaded onto a 5 mL Ni-NTA
column, and the fractions were eluted with a step gradient from 5 to 500 mM imidazole.
Fractions containing the Mac1 domain protein (5 mL total) were loaded on a 250 mL
Sephacryl S300 gel filtration column and eluted with 10 mM MOPS and 150 mM NaCl. Purified
protein concentrations were determined by measuring the absorbance at 260 nm using a molar
extinction coefficient of 10555 M<sup>&#x02013;1</sup> cm<sup>&#x02013;1</sup>, which was
calculated using the ProtParam tool (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://web.expasy.org/protparam/">https://web.expasy.org/protparam/</uri>).</p></sec><sec id="sec2.3"><title>Isothermal Titration Calorimetry (ITC)</title><p>Binding of ADP-ribose to the SARS-CoV-2 Mac1 domain was measured using a Nano ITC
apparatus (TA Instruments). Before the measurement was started, samples of both ligand and
protein were diluted in 10 mM MOPS and 150 mM NaCl (pH 7) and degassed at 400 mmHg for 30
min. Measurements were taken at 20 &#x000b0;C by injecting 2.0 &#x003bc;L aliquots of 500
&#x003bc;M ADP-ribose (Sigma) into 50 &#x003bc;M protein (175 &#x003bc;L initial volume) with
stirring at 250 rpm. Using NanoAnalyze Software (version 3.11.0), data were fitted by
nonlinear regression to an independent binding model. Briefly, after baseline correction,
background heats from ligand-to-buffer titrations were subtracted, and the corrected heats
from the binding reaction were used to identify best fit parameters for the stoichiometry
of binding (<italic>n</italic>), free energy of binding (&#x00394;<italic>G</italic>),
apparent enthalpy of binding (&#x00394;<italic>H</italic>), and entropy change
(&#x00394;<italic>S</italic>). Dissociation constants (<italic>K</italic><sub>d</sub>)
were calculated from the &#x00394;<italic>G</italic>.</p></sec><sec id="sec2.4"><title>Crystallization and Structure Determination</title><p>In preparation for crystallization experiments, purified SARS-CoV-2 Mac1 domain protein
was cleaved with tobacco etch virus (TEV) protease to remove the N-terminal
His<sub>6</sub> tag and passed back through the Ni-NTA column. The flow-through
fractions were desalted into 10 mM HEPES (pH 7.2) using a 2 &#x000d7; 5 mL HiTrap desalting
column (GE Life Sciences) and concentrated to 10 mg/mL in a centrifugal concentrator. This
preparation of the protein was mixed at a 1:1 &#x003bc;L ratio with Morpheus HT screen
reagents (Molecular Dimensions) in a 96-well SwissSci MRC ultraviolet-transmissible
sitting drop plate. Large, diffraction-quality crystals grew directly from a number of the
screen conditions. The crystal ultimately used for structure determination grew from
condition D9: 0.12 M alcohols (0.02 M each 1,6-hexanediol, 1-butanol, 1,2-propanediol,
2-propanol, 1,4-butanediol, and 1,3-propanediol), 0.1 M buffer system 3, pH 8.5 (0.05 M
Tris and 0.05 M bicine), and 30% precipitant mix 1 [20% poly(ethylene glycol) (PEG) 500
monomethylether and 10% PEG 20000]. Large, thick plates grew within 1 week at 22 &#x000b0;C.
Given the high concentration of PEG 500 MME, the crystal did not require additional
cryo-protection and was flash-cooled by being directly looped from the sitting drop and
plunged into liquid nitrogen.</p><p>Diffraction data were collected on Life Sciences Collaborative Access Team (LS-CAT)
beamline 21-ID-F at the Advanced Photon Source of Argonne National Laboratory. The
wavelength at this station is fixed at 0.9787 &#x000c5;; the detector is a MarMosaic M300
charge-coupled device. The data were collected with an oscillation width of 0.5&#x000b0; per
image for a total oscillation of 180&#x000b0;. The data were indexed and integrated with
DIALS<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> as
implemented in version 7.2 of the CCP4 software suite.<sup><xref ref-type="bibr" rid="ref17">17</xref>,<xref ref-type="bibr" rid="ref18">18</xref></sup> Data scaling and reduction were performed
using AIMLESS.<sup><xref ref-type="bibr" rid="ref19">19</xref>&#x02212;<xref ref-type="bibr" rid="ref21">21</xref></sup> Data collection
statistics are listed in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Crystallographic Data Collection and Model Refinement Statistics for the
SARS-CoV-2 Mac1 Domain</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/></colgroup><tbody><tr><td colspan="2" style="border:none;" align="center">Data Collection</td></tr><tr><td style="border:none;" align="left">resolution range (&#x000c5;) (last shell)<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">43.32&#x02013;0.95 (0.97&#x02013;0.95)</td></tr><tr><td style="border:none;" align="left">space group</td><td style="border:none;" align="left"><italic>P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td></tr><tr><td style="border:none;" align="left"><italic>a</italic>, <italic>b</italic>, <italic>c</italic> (&#x000c5;)</td><td style="border:none;" align="left">43.3, 54.4, 67.6</td></tr><tr><td style="border:none;" align="left">&#x003b1;, &#x003b2;, &#x003b3; (deg)</td><td style="border:none;" align="left">90.0, 90.0, 90.0</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>merge</sub><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">0.063&#x000a0;(0.348)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>meas</sub><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">0.075&#x000a0;(0.475)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>pim</sub><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">0.039&#x000a0;(0.320)</td></tr><tr><td style="border:none;" align="left">CC<sub>1/2</sub><xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">99.5&#x000a0;(89.1)</td></tr><tr><td style="border:none;" align="left">no. of unique reflections<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">99442&#x000a0;(4199)</td></tr><tr><td style="border:none;" align="left">completeness (%)<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">98.4&#x000a0;(85.0)</td></tr><tr><td style="border:none;" align="left">multiplicity<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">6.4 (2.6)</td></tr><tr><td style="border:none;" align="left">&#x027e8;<italic>I</italic>/&#x003c3;(<italic>I</italic>)&#x027e9;<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">13.1 (1.5)</td></tr><tr><td colspan="2" style="border:none;" align="center">Model Refinement</td></tr><tr><td style="border:none;" align="left">no. of reflections used in refinement</td><td style="border:none;" align="left">99335&#x000a0;(2606)<xref rid="t1fn2" ref-type="table-fn">b</xref></td></tr><tr><td style="border:none;" align="left">no.f of reflections used for <italic>R</italic><sub>free</sub></td><td style="border:none;" align="left">5046&#x000a0;(125)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>cryst</sub>
(<italic>R</italic><sub>free</sub>)</td><td style="border:none;" align="left">0.119&#x000a0;(0.137)</td></tr><tr><td style="border:none;" align="left">Wilson <italic>B</italic>-factor (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">7.4</td></tr><tr><td style="border:none;" align="left">average <italic>B</italic>-factor (&#x000c5;<sup>2</sup>)</td><td style="border:none;" align="left">13.9</td></tr><tr><td style="padding-left: 2em;" align="left">protein atoms</td><td style="border:none;" align="left">10.2</td></tr><tr><td style="padding-left: 2em;" align="left">solvent</td><td style="border:none;" align="left">28.2</td></tr><tr><td style="border:none;" align="left">root-mean-square (RMS) deviation</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left">bond lengths (&#x000c5;)</td><td style="border:none;" align="left">0.010</td></tr><tr><td style="padding-left: 2em;" align="left">bond angles (deg)</td><td style="border:none;" align="left">1.16</td></tr><tr><td style="padding-left: 2em;" align="left">coordinate error (&#x000c5;)</td><td style="border:none;" align="left">0.06</td></tr><tr><td style="border:none;" align="left">Ramachandran statistics</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left">favored/allowed/outliers
(%)</td><td style="border:none;" align="left">98.2/1.8/0.0</td></tr><tr><td style="padding-left: 2em;" align="left">rotamer outliers (%)</td><td style="border:none;" align="left">1.2</td></tr><tr><td style="border:none;" align="left">Clashscore</td><td style="border:none;" align="left">1.70</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Values in parentheses apply to the high-resolution shell indicated in the
resolution row.</p></fn><fn id="t1fn2"><label>b</label><p>The limits of the high-resolution bin for refinement were 0.96&#x02013;0.95
&#x000c5;.</p></fn></table-wrap-foot></table-wrap><p>The structure was determined by molecular replacement in PHASER<sup><xref ref-type="bibr" rid="ref22">22</xref></sup>
using the model of the SARS-CoV Mac1 domain as the search model [Protein Data Bank (PDB)
entry 2FAV(<xref ref-type="bibr" rid="ref14">14</xref>)].
The model underwent iterative rounds of (re)building in COOT<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> and
refinement in PHENIX.refine.<sup><xref ref-type="bibr" rid="ref24">24</xref>,<xref ref-type="bibr" rid="ref25">25</xref></sup> The very high resolution of the data justified a full anisotropic
treatment of the protein and solvent temperature factors. Model refinement and validation
statistics are listed in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. The coordinates
were deposited in the Protein Data Bank as entry 6WEY.</p></sec></sec><sec id="sec3"><title>Results and Discussion</title><sec id="sec3.1"><title>Variability in the nsp3 Mac1 Domain</title><p>The structures of most of the soluble portions of the SARS-CoV nsp proteins were examined
at atomic resolution to help understand coronavirus replication and facilitate antiviral
drug discovery. The amino acid sequences of each of these proteins were compared with the
homologous regions of the rep 1ab protein encoded by SARS-CoV-2 (GenPept accession number
YP_009724389). The most similar proteins were the RNA helicases (nsp13), which are
identical in all but one of their 603 amino acids, namely a conservative Val to Ile
substitution near their C-termini. The RNA-dependent RNA polymerases (nsp12) are also well
conserved, sharing all but 34 of 955 amino acids. The primary protease that cleaves the
polyprotein (nsp5) is also similar in SARS-CoV and SARS-CoV-2, with only 13 amino acids
that differ among 306 (4.2% different) (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><p>At the other end of the spectrum are the nsp3 proteins, which are notably more different
in the two SARS viruses. nsp3 is a large multidomain membrane-bound protein,<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> and its clearest role in viral replication is cleaving the rep
polyprotein. Greater than 17% of the amino acids in the nsp3 protease domain differ
between SARS-CoV and SARS-CoV-2. Other parts of nsp3 are even more variable, such as the
macrodomains that lie N-terminal to the nsp3 protease domain. Macrodomains consist of four
helices that surround a mixed &#x003b2; sheet. A ligand-binding pocket that typically binds
ADP-ribose or related compounds lies between the helices and the sheet.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup> SARS-CoV has three macrodomains in tandem, but only the first binds ADP-ribose. The
amino acid sequences of this Mac1 domain differ by 26% between SARS-CoV and SARS-CoV-2
(<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).</p><p>Six of the 47 variant residues in the 180-amino acid SARS Mac1 domain are clustered in a
21-amino acid region near its N-terminus, which is particularly variable in the three
Coronaviridae genera (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) and sometimes not
included in other macrodomains. As shown by the conservation plot above the alignment
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>), there are several highly variable
regions throughout the protein, which might affect protein function. Mac1 domains from
coronaviruses that cause the common cold (alpha coronaviruses)<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> and
the beta coronaviruses, such as SARS-CoV and Middle East respiratory syndrome coronavirus
(MERS-CoV),<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> all bind ADP-ribose. However, reports with gamma
coronaviruses suggest that ADP-ribose binding might not be conserved. Sequence differences
exist between infectious bronchitis virus (IBV) strain M41, which binds ADP-ribose, and
IBV strain Beaudette, which does not.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup></p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Variation in the Mac1 domains of coronaviruses. Mac1 structures were aligned using
the &#x0201c;MatchMaker&#x0201d; function of UCSF Chimera (version 1.14).<sup><xref ref-type="bibr" rid="ref40">40</xref></sup> Amino acids are colored by class. &#x003b2; sheets are denoted with
green boxes, and &#x003b1; helices are denoted with yellow boxes. Arrows mark key
residues F360, F336, D226, and N244 (see the text).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi0c00309_0002" id="gr2" position="float"/></fig></sec><sec id="sec3.2"><title>Expression and Purification of the SARS-CoV-2 Mac1 Domain</title><p>An <italic>Escherichia coli</italic> expression vector for the Mac1 domain was generated
to express an N-terminally His-tagged protein similar to a SARS-CoV protein studied by
Egloff et al.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> Upon induction, a 1 L culture of BL21(DE3) cells
harboring the vector expresses 50&#x02013;100 mg of the Mac1 domain protein that can be
purified in one step to apparent homogeneity using immobilized metal affinity
chromatography (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>A). The protein was
polished further with gel filtration chromatography and concentrated before analysis and
crystallization.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>SARS-CoV-2 Mac1 domain binds ADP ribose. (A) A 15% sodium dodecyl
sulfate&#x02013;polyacrylamide gel electrophoresis gel showing 10 &#x003bc;L samples of a
soluble crude lysate of induced BL21(DE3) cells harboring plasmid p21-COVID-Mac1 (lane
C), proteins that do not bind a Ni-NTA column (F), and fractions eluted from a
Ni-nitrilotriacetic acid column during an imidazole step gradient from 0 mM (lanes
1&#x02013;3) to 5 mM (lanes 4&#x02013;6), 40 mM (lanes 7&#x02013;9), and 500 mM (lanes
10&#x02013;12). Protein markers (lane M) are 116, 66.2, 45, 35, and 25 kDa. (B) Example
ITC experiment in which the purified SARS-CoV-2 nsp3 macrodomain was titrated with ADP
ribose. (C) ITC experiments such as those shown in panel B were repeated thrice with
each of the compounds listed. Means are plotted, and error bars are standard
deviations. Average (&#x000b1;SD) dissociation constants were 10 &#x000b1; 4 &#x003bc;M for
ADP-ribose, 8 &#x000b1; 9 &#x003bc;M for ADP, 3 &#x000b1; 3 &#x003bc;M for ATP, 6 &#x000b1; 4
&#x003bc;M for ADP-glucose, 2 &#x000b1; 1 &#x003bc;M for cAMP, and 2 &#x000b1; 1 &#x003bc;M for
adenosine. (D) Comparison of the thermodynamics of ADP-ribose binding by Mac1 domains
from SARS-CoV-2 (data from panel C), SARS-CoV, MERS-CoV, and an alpha coronavirus.
<sup>a</sup>Data from ref (<xref ref-type="bibr" rid="ref34">34</xref>)<sup>b</sup>Data from ref (<xref ref-type="bibr" rid="ref39">39</xref>).
<sup>c</sup>Data from ref (<xref ref-type="bibr" rid="ref13">13</xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi0c00309_0003" id="gr3" position="float"/></fig></sec><sec id="sec3.3"><title>Nucleotide Binding by the SARS-CoV-2 Mac1 Domain</title><p>Repeated ITC experiments revealed that the purified recombinant protein bound ADP-ribose
(<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>C) with a dissociation constant of 10
&#x000b1; 4 &#x003bc;M (the uncertainty is the standard deviation of
<italic>K</italic><sub>d</sub>s from independent titrations). To examine binding
specificity, similar titrations were repeated with related nucleotides. The SARS-CoV-2
protein bound ADP, cAMP, ATP, and ADP-glucose (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>D). All nucleotides lacking the ribose moiety bound with similar high
affinities, but none bound with an enthalpy change similar to that observed with
ADP-ribose, suggesting specific contacts form between ADP-ribose and the SARS-CoV-2
protein. On the basis of findings from the SARS-CoV-2 structures below, these contacts
likely occur with the conserved D226 and N244 (positions 30 and 43, respectively, in the
numbering above the alignment in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). None
of the other nucleotides bind with an entropic penalty as observed with ADP-ribose,
suggesting that the ribose moiety becomes structured when bound to the macrodomain.</p><p>The energetics of binding of ADP-ribose to the SARS-CoV protein are similar to those
noted for the same protein from SARS-CoV<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and MERS-CoV.<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> The enthalpy and entropy of binding were also very similar for all three
proteins (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>D). In contrast to findings
from the Mac1 protein from an alpha coronavirus,<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> enthalpy appears to
drive binding of ADP-ribose to the Mac1 domains of the three beta coronaviruses. Variation
in the ADP-ribose-binding cleft might account for these differences. For example, nsp3
amino acid 360, which is near the adenine base, is a Phe in SARS-CoV-2, an Asn in both
SARS-CoV and MERS-CoV, and an aliphatic amino acid in the alpha and gamma coronaviruses
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>)</p></sec><sec id="sec3.4"><title>Structure of the SARS-CoV-2 Mac1 Domain</title><p>The SARS-CoV-2 Mac1 domain (nsp3 residues 207&#x02013;277) crystallized in space group
<italic>P</italic>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> with one molecule per
asymmetric unit. These crystals had a solvent content of 43% and diffracted extremely
well. The final resolution limit of the data was set at 0.95 &#x000c5; (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). The quality of the electron density maps is
correspondingly excellent (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>A). The
section of the structure depicted in this image is located on the surface of the protein,
and the <italic>B</italic>-factors of these residues (7.2 &#x000c5;<sup>2</sup>) are close to
the average <italic>B</italic>-factor of the protein (10.2 &#x000c5;<sup>2</sup>), indicating
that this sample accurately represents the overall quality of the maps. The final model
contains the entire sequence from V207 to S377 of nsp3, an N-terminal glycine residue that
was left from the TEV-protease cleavage, and 374 solvent molecules. The
<italic>R</italic><sub>cryst</sub> and <italic>R</italic><sub>free</sub> values of the
final model were 0.119 and 0.137, respectively (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>).</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>SARS-CoV-2 Mac1 domain structure. (A) The electron density is shown for a
representative portion of the structure (residues 359&#x02013;361) on the surface of
the protein. The 2<italic>mF</italic><sub>o</sub> &#x02013;
<italic>DF</italic><sub>c</sub> map is contoured at 1.5&#x003c3; and is shown as a
magenta mesh. The <italic>mF</italic><sub>o</sub> &#x02013;
<italic>DF</italic><sub>c</sub> (difference) maps are shown at +3.0&#x003c3; and
&#x02212;3.0&#x003c3; as green and red mesh, respectively. (B) Ribbon diagram of the
SARS-CoV-2 Mac1 domain structure colored according to the sequence conservation plot
in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref> as a gradient from red (weakly
conserved, &#x0003c;10%) to blue (strongly conserved, 100%) through magenta. As observed in
the sequence alignment, the N- and C-termini are particularly poorly conserved. (C)
Overlay of the structure of the SARS-CoV-2 Mac1 domain bound to ADP-ribose determined
by Michalska et al. of the CGSID (PDB entry 6W02) with the ultra-high-resolution structure of the
unliganded protein determined here. ADP-ribose is presented as a ball-and-stick model
with the carbon atoms colored gold. The backbone trace of the unliganded structure is
colored cyan, and that of the ADP-ribose-bound model is colored gray. There are three
loops with significantly different conformations in the two structures. In the
unliganded structure, the &#x003b2;2&#x02212;&#x003b1;2 loop is colored bright red, the
&#x003b2;4&#x02212;&#x003b1;4 loop is colored purple, and the &#x003b2;5&#x02212;&#x003b1;5 loop
is colored bright green. The same regions of the ADP-ribose-bound structure are
colored pale red, pale purple, and pale green, respectively. The transparent blue and
yellow spheres represent water molecules bound to the unliganded (transparent blue)
and ADP-ribose-bound (transparent yellow) forms of the protein. Interestingly, several
of the water molecules interacting with ADP-ribose in PDB entry 6W02 can also be found in the
unliganded structure of the protein. The inset shows a close-up of the boxed region
colored according to the same scheme. The &#x003b2;2&#x02212;&#x003b1;2 and
&#x003b2;5&#x02212;&#x003b1;5 loops, which contact ADP-ribose, are presented as a
ball-and-stick model. Note that the &#x003b2;2&#x02212;&#x003b1;2 loop rotates
&#x0223c;180&#x000b0; to allow it to make a hydrogen bonding interaction with the
1&#x02032;-hydroxyl of the ribose moiety. Additionally, the phenylalanine residue in
the &#x003b2;5&#x02212;&#x003b1;5 loop (F336) would clash with the &#x003b2;-phosphate and
ribose of ADP-ribose if the &#x003b2;5&#x02212;&#x003b1;5 loop did not adopt a different
conformation.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi0c00309_0004" id="gr4" position="float"/></fig><p>As expected, the tertiary structure ranges from approximately identical to very similar
to those of other coronavirus macrodomains, including SARS CoV (2FAV,<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> 74.7% sequence
identity) with a root-mean-square deviation (RMSD) value for 162 of 172 C&#x003b1; atoms of
0.6 &#x000c5;, MERS-CoV (5DUS,<sup><xref ref-type="bibr" rid="ref39">39</xref></sup> 42.2% identical) with a 1.2 &#x000c5; RMSD for 161 of 172 C&#x003b1; atoms,
human alpha coronavirus 229E (3EWR,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> 32.5% identical) with a 1.5 &#x000c5; RMSD for 154 of
172 C&#x003b1; atoms, feline coronavirus (FCoV, 3JZT,<sup><xref ref-type="bibr" rid="ref42">42</xref></sup> 26.8% identical) with a 1.5 &#x000c5; RMSD for 153 of
172 C&#x003b1; atoms, and the gamma CoV IBV (3EWP,<sup><xref ref-type="bibr" rid="ref41">41</xref></sup> 26.7% identical) with a 2.1 &#x000c5; RMSD for 150 of
172 C&#x003b1; atoms. The regions with a high degree of sequence conservation are not
clustered in any particular region(s) of the molecule, as is clear when the ribbon is
colored as a gradient from red (poorly conserved) to blue (highly conserved) (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>B). This finding is consistent with the fact
that the protein atoms involved in hydrogen bonding interactions with the ligands in these
structures are more often part of the main chain; relatively few interactions of side
chains with ligands are observed.</p><p>At the time of writing, we discovered that Michalska et al. of the Center for Structural
Genomics of Infectious Diseases (CSGID) deposited coordinates for a very similar construct
of the SARS-CoV-2 Mac1 domain including the region from E206 to E275 of the nsp3 protein
plus an additional four residues at the N-terminus (6VSX, unpublished). Their crystals also allowed binding of
ADP-ribose (6W02) and AMP (6W6Y), whereas ours seemed to be packed too
tightly to permit ligands to access the binding site (data not shown). We compared our
ultra-high-resolution model of the unliganded protein to the ADP-ribose-bound form. The
RMSD for the fitting, which were determined by secondary structure matching (SSM)<sup><xref ref-type="bibr" rid="ref43">43</xref></sup> as implemented in COOT, is 0.59 &#x000c5; for 165 of 172 C&#x003b1; atoms. This
value is very similar to the RMSD values of the free protein (6VXS, 0.66 &#x000c5;) and the AMP-bound form
(6W6Y, 0.50 &#x000c5;), indicating
that no large conformational changes occur upon ligand binding. In fact, the only notable
conformational changes occur in three surface-exposed loops in or near the ligand-binding
pocket (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C). These loops connect strand
&#x003b2;2 with helix &#x003b1;2 (the &#x003b2;2&#x02212;&#x003b1;2 loop), strand &#x003b2;4 with
helix &#x003b1;4 (the &#x003b2;4&#x02212;&#x003b1;4 loop), and strand &#x003b2;5 with helix
&#x003b1;5 (the &#x003b2;5&#x02212;&#x003b1;5 loop). The subtle change in conformation of the
&#x003b2;4&#x02212;&#x003b1;4 loop (purple in <xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>C) appears to be the result of crystal contacts and not the direct influence of
ADP-ribose binding. The other two loops are more intimately involved in ligand binding.
The main chain of the &#x003b1;2&#x02212;&#x003b2;2 loop rotates 180&#x000b0; to allow the amide N
atom of G252 to participate in a hydrogen bonding interaction with the 1&#x02032;-hydroxyl
of the ribose moiety of ADP-ribose. G252 corresponds to residue V33 in the Chikungunya
macrodomain, which Eckei et al. proposed is needed for de-ADP-ribosylation activity based
on results of site-directed mutagenesis.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> This loop also carries N244,
which directly interacts with the ribose. The phenyl ring of F336 in the
&#x003b2;5&#x02212;&#x003b1;5 loop occupies the portion of the binding pocket in the unliganded
structure that is occupied by the &#x003b2;-phosphate of ADP-ribose. Thus, without
rearrangement of the &#x003b2;5&#x02212;&#x003b1;5 loop, ADP-ribose would not be able to
bind.</p></sec></sec><sec id="sec4"><title>Conclusion</title><p>The significance of the study stems mainly from the demonstration that the SARS-CoV-2 Mac1
domain binds ADP-ribose. Although SARS-CoV and SARS-CoV-2 have 26% divergence in amino acid
sequences, their structures are highly similar, which may explain the ability of the latter
to bind ADP-ribose. This is the first step needed to justify screens for potential
antivirals that bind in place of ADP-ribose. However, more work needs to be done to
understand the antiviral potential of such compounds because the biological role for
ADP-ribose binding is not completely understood. Some work with alpha coronaviruses suggests
that ADP-ribose binding by the Mac1 domain is not required for viral replication.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> However, studies with other (+)RNA viruses suggest that macrodomains are
essential for virulence.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> This work is also noteworthy because the
synthetic codon-optimized plasmid reported here produces up to 100 mg of soluble Mac1 domain
protein per liter of <italic>E. coli</italic> culture, and this protein retains a high
affinity for ADP-ribose. The protein could be used for structural studies and screening
campaigns. Screening assays with the SARS-CoV-2 protein might be more efficient because the
SARS-CoV-2 protein binds ADP-ribose somewhat more tightly (<italic>K</italic><sub>d</sub> =
10 &#x003bc;M) than the SARS-CoV protein (<italic>K</italic><sub>d</sub> = 24 &#x003bc;M). The
recombinant protein reported here together with detailed structural information might also
be useful to others developing SARS-CoV-2 diagnostics and/or therapeutics.</p></sec></body><back><notes notes-type="accession-codes" id="notes2"><title>Accession Codes</title><p>SARS-CoV-2 Rep 1ab, YP_009724389 (NCBI); SARS-CoV-2 Mac1, 6WEY (PDB).</p></notes><notes notes-type="funding-statement" id="notes1"><p>This work was supported by National Institutes of Health Grant R01 AI088001 (to D.N.F.) and
National Science Foundation Grant CHE-1903899 (to N.R.S.).</p></notes><notes notes-type="COI-statement" id="NOTES-d7e935-autogenerated"><p>The authors declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>The authors are grateful to Matt McCarty, Garrett Breit, Hayden Aristizabal, Trevor R.
Melkonian, Dante A. Serrano, and Prof. Ionel Popa for valuable technical assistance and
helpful discussions. This research used resources of the Advanced Photon Source, a U.S.
Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of
Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of LS-CAT
Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan
Technology Tri-Corridor (Grant 085P1000817).</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Wu</surname><given-names>F.</given-names></name>; <name><surname>Zhao</surname><given-names>S.</given-names></name>; <name><surname>Yu</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>Y. M.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Song</surname><given-names>Z. G.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Tao</surname><given-names>Z. W.</given-names></name>; <name><surname>Tian</surname><given-names>J. H.</given-names></name>; <name><surname>Pei</surname><given-names>Y. Y.</given-names></name>; <name><surname>Yuan</surname><given-names>M. L.</given-names></name>; <name><surname>Zhang</surname><given-names>Y. L.</given-names></name>; <name><surname>Dai</surname><given-names>F. H.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Q. M.</given-names></name>; <name><surname>Zheng</surname><given-names>J. J.</given-names></name>; <name><surname>Xu</surname><given-names>L.</given-names></name>; <name><surname>Holmes</surname><given-names>E. C.</given-names></name>; <name><surname>Zhang</surname><given-names>Y. Z.</given-names></name> (<year>2020</year>) <article-title>A new coronavirus associated with human respiratory disease in
China</article-title>. <source>Nature</source>
<volume>579</volume>, <fpage>265</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id>.<pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Subissi</surname><given-names>L.</given-names></name>; <name><surname>Imbert</surname><given-names>I.</given-names></name>; <name><surname>Ferron</surname><given-names>F.</given-names></name>; <name><surname>Collet</surname><given-names>A.</given-names></name>; <name><surname>Coutard</surname><given-names>B.</given-names></name>; <name><surname>Decroly</surname><given-names>E.</given-names></name>; <name><surname>Canard</surname><given-names>B.</given-names></name> (<year>2014</year>) <article-title>SARS-CoV ORF1b-encoded nonstructural proteins 12&#x02013;16: replicative
enzymes as antiviral targets</article-title>. <source>Antiviral Res.</source>
<volume>101</volume>, <fpage>122</fpage>&#x02013;<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.11.006</pub-id>.<pub-id pub-id-type="pmid">24269475</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Neuman</surname><given-names>B. W.</given-names></name> (<year>2016</year>) <article-title>Bioinformatics and functional analyses of coronavirus nonstructural
proteins involved in the formation of replicative organelles</article-title>. <source>Antiviral Res.</source>
<volume>135</volume>, <fpage>97</fpage>&#x02013;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.10.005</pub-id>.<pub-id pub-id-type="pmid">27743916</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Kusov</surname><given-names>Y.</given-names></name>; <name><surname>Tan</surname><given-names>J.</given-names></name>; <name><surname>Alvarez</surname><given-names>E.</given-names></name>; <name><surname>Enjuanes</surname><given-names>L.</given-names></name>; <name><surname>Hilgenfeld</surname><given-names>R.</given-names></name> (<year>2015</year>) <article-title>A G-quadruplex-binding macrodomain within the &#x0201c;SARS-unique
domain&#x0201d; is essential for the activity of the SARS-coronavirus
replication-transcription complex</article-title>. <source>Virology</source>
<volume>484</volume>, <fpage>313</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2015.06.016</pub-id>.<pub-id pub-id-type="pmid">26149721</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Saikatendu</surname><given-names>K. S.</given-names></name>; <name><surname>Joseph</surname><given-names>J. S.</given-names></name>; <name><surname>Subramanian</surname><given-names>V.</given-names></name>; <name><surname>Clayton</surname><given-names>T.</given-names></name>; <name><surname>Griffith</surname><given-names>M.</given-names></name>; <name><surname>Moy</surname><given-names>K.</given-names></name>; <name><surname>Velasquez</surname><given-names>J.</given-names></name>; <name><surname>Neuman</surname><given-names>B. W.</given-names></name>; <name><surname>Buchmeier</surname><given-names>M. J.</given-names></name>; <name><surname>Stevens</surname><given-names>R. C.</given-names></name>; <name><surname>Kuhn</surname><given-names>P.</given-names></name> (<year>2005</year>) <article-title>Structural basis of severe acute respiratory syndrome coronavirus
ADP-ribose-1&#x02032;&#x02032;-phosphate dephosphorylation by a conserved domain of
nsP3</article-title>. <source>Structure</source>
<volume>13</volume>, <fpage>1665</fpage>&#x02013;<lpage>1675</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2005.07.022</pub-id>.<pub-id pub-id-type="pmid">16271890</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Debing</surname><given-names>Y.</given-names></name>; <name><surname>Jankevicius</surname><given-names>G.</given-names></name>; <name><surname>Neyts</surname><given-names>J.</given-names></name>; <name><surname>Ahel</surname><given-names>I.</given-names></name>; <name><surname>Coutard</surname><given-names>B.</given-names></name>; <name><surname>Canard</surname><given-names>B.</given-names></name> (<year>2016</year>) <article-title>Viral Macro Domains Reverse Protein ADP-Ribosylation</article-title>. <source>J. Virol.</source>
<volume>90</volume>, <fpage>8478</fpage>&#x02013;<lpage>8486</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00705-16</pub-id>.<pub-id pub-id-type="pmid">27440879</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Fehr</surname><given-names>A. R.</given-names></name>; <name><surname>Channappanavar</surname><given-names>R.</given-names></name>; <name><surname>Jankevicius</surname><given-names>G.</given-names></name>; <name><surname>Fett</surname><given-names>C.</given-names></name>; <name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Athmer</surname><given-names>J.</given-names></name>; <name><surname>Meyerholz</surname><given-names>D. K.</given-names></name>; <name><surname>Ahel</surname><given-names>I.</given-names></name>; <name><surname>Perlman</surname><given-names>S.</given-names></name> (<year>2016</year>) <article-title>The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the
Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus
Infection</article-title>. <source>mBio</source>
<volume>7</volume>, <fpage>7</fpage><pub-id pub-id-type="doi">10.1128/mBio.01721-16</pub-id>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Fehr</surname><given-names>A. R.</given-names></name>; <name><surname>Jankevicius</surname><given-names>G.</given-names></name>; <name><surname>Ahel</surname><given-names>I.</given-names></name>; <name><surname>Perlman</surname><given-names>S.</given-names></name> (<year>2018</year>) <article-title>Viral Macrodomains: Unique Mediators of Viral Replication and
Pathogenesis</article-title>. <source>Trends Microbiol.</source>
<volume>26</volume>, <fpage>598</fpage>&#x02013;<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2017.11.011</pub-id>.<pub-id pub-id-type="pmid">29268982</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Alhammad</surname><given-names>Y. M. O.</given-names></name>; <name><surname>Fehr</surname><given-names>A. R.</given-names></name> (<year>2020</year>) <article-title>The Viral Macrodomain Counters Host Antiviral
ADP-Ribosylation</article-title>. <source>Viruses</source>
<volume>12</volume> (<issue>4</issue>), <fpage>384</fpage><pub-id pub-id-type="doi">10.3390/v12040384</pub-id>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Eckei</surname><given-names>L.</given-names></name>; <name><surname>Krieg</surname><given-names>S.</given-names></name>; <name><surname>B&#x000fc;tepage</surname><given-names>M.</given-names></name>; <name><surname>Lehmann</surname><given-names>A.</given-names></name>; <name><surname>Gross</surname><given-names>A.</given-names></name>; <name><surname>Lippok</surname><given-names>B.</given-names></name>; <name><surname>Grimm</surname><given-names>A. R.</given-names></name>; <name><surname>K&#x000fc;mmerer</surname><given-names>B. M.</given-names></name>; <name><surname>Rossetti</surname><given-names>G.</given-names></name>; <name><surname>L&#x000fc;scher</surname><given-names>B.</given-names></name>; <name><surname>Verheugd</surname><given-names>P.</given-names></name> (<year>2017</year>) <article-title>The conserved macrodomains of the non-structural proteins of Chikungunya
virus and other pathogenic positive strand RNA viruses function as
mono-ADP-ribosylhydrolases</article-title>. <source>Sci. Rep.</source>
<volume>7</volume>, <fpage>41746</fpage><pub-id pub-id-type="doi">10.1038/srep41746</pub-id>.<pub-id pub-id-type="pmid">28150709</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>McPherson</surname><given-names>R. L.</given-names></name>; <name><surname>Abraham</surname><given-names>R.</given-names></name>; <name><surname>Sreekumar</surname><given-names>E.</given-names></name>; <name><surname>Ong</surname><given-names>S. E.</given-names></name>; <name><surname>Cheng</surname><given-names>S. J.</given-names></name>; <name><surname>Baxter</surname><given-names>V. K.</given-names></name>; <name><surname>Kistemaker</surname><given-names>H. A.</given-names></name>; <name><surname>Filippov</surname><given-names>D. V.</given-names></name>; <name><surname>Griffin</surname><given-names>D. E.</given-names></name>; <name><surname>Leung</surname><given-names>A. K.</given-names></name> (<year>2017</year>) <article-title>ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical
for virus replication and virulence</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>114</volume>, <fpage>1666</fpage>&#x02013;<lpage>1671</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1621485114</pub-id>.<pub-id pub-id-type="pmid">28143925</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Claverie</surname><given-names>J. M.</given-names></name> (<year>2020</year>) <article-title>A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3
Protein in the Cytokine Storm Syndrome of COVID-19</article-title>. <source>Viruses</source>
<volume>12</volume> (<issue>16</issue>), <fpage>E646</fpage><pub-id pub-id-type="doi">10.3390/v12060646</pub-id>.<pub-id pub-id-type="pmid">32549200</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Piotrowski</surname><given-names>Y.</given-names></name>; <name><surname>Hansen</surname><given-names>G.</given-names></name>; <name><surname>Boomaars-van der Zanden</surname><given-names>A. L.</given-names></name>; <name><surname>Snijder</surname><given-names>E. J.</given-names></name>; <name><surname>Gorbalenya</surname><given-names>A. E.</given-names></name>; <name><surname>Hilgenfeld</surname><given-names>R.</given-names></name> (<year>2008</year>) <article-title>Crystal structures of the X-domains of a Group-1 and a Group-3 coronavirus
reveal that ADP-ribose-binding may not be a conserved property</article-title>. <source>Protein Sci.</source>
<volume>18</volume>, <fpage>6</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1002/pro.15</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Egloff</surname><given-names>M. P.</given-names></name>; <name><surname>Malet</surname><given-names>H.</given-names></name>; <name><surname>Putics</surname><given-names>A.</given-names></name>; <name><surname>Heinonen</surname><given-names>M.</given-names></name>; <name><surname>Dutartre</surname><given-names>H.</given-names></name>; <name><surname>Frangeul</surname><given-names>A.</given-names></name>; <name><surname>Gruez</surname><given-names>A.</given-names></name>; <name><surname>Campanacci</surname><given-names>V.</given-names></name>; <name><surname>Cambillau</surname><given-names>C.</given-names></name>; <name><surname>Ziebuhr</surname><given-names>J.</given-names></name>; <name><surname>Ahola</surname><given-names>T.</given-names></name>; <name><surname>Canard</surname><given-names>B.</given-names></name> (<year>2006</year>) <article-title>Structural and functional basis for ADP-ribose and poly(ADP-ribose) binding
by viral macro domains</article-title>. <source>J. Virol.</source>
<volume>80</volume>, <fpage>8493</fpage>&#x02013;<lpage>8502</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00713-06</pub-id>.<pub-id pub-id-type="pmid">16912299</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Clabbers</surname><given-names>M. T. B.</given-names></name>; <name><surname>Gruene</surname><given-names>T.</given-names></name>; <name><surname>Parkhurst</surname><given-names>J. M.</given-names></name>; <name><surname>Abrahams</surname><given-names>J. P.</given-names></name>; <name><surname>Waterman</surname><given-names>D. G.</given-names></name> (<year>2018</year>) <article-title>Electron diffraction data processing with DIALS</article-title>. <source>Acta Crystallogr D Struct Biol</source>
<volume>74</volume>, <fpage>506</fpage>&#x02013;<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1107/S2059798318007726</pub-id>.<pub-id pub-id-type="pmid">29872002</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Winter</surname><given-names>G.</given-names></name>; <name><surname>Waterman</surname><given-names>D. G.</given-names></name>; <name><surname>Parkhurst</surname><given-names>J. M.</given-names></name>; <name><surname>Brewster</surname><given-names>A. S.</given-names></name>; <name><surname>Gildea</surname><given-names>R. J.</given-names></name>; <name><surname>Gerstel</surname><given-names>M.</given-names></name>; <name><surname>Fuentes-Montero</surname><given-names>L.</given-names></name>; <name><surname>Vollmar</surname><given-names>M.</given-names></name>; <name><surname>Michels-Clark</surname><given-names>T.</given-names></name>; <name><surname>Young</surname><given-names>I. D.</given-names></name>; <name><surname>Sauter</surname><given-names>N. K.</given-names></name>; <name><surname>Evans</surname><given-names>G.</given-names></name> (<year>2018</year>) <article-title>DIALS: implementation and evaluation of a new integration
package</article-title>. <source>Acta Crystallogr D Struct Biol</source>
<volume>74</volume>, <fpage>85</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1107/S2059798317017235</pub-id>.<pub-id pub-id-type="pmid">29533234</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Winn</surname><given-names>M. D.</given-names></name>; <name><surname>Ballard</surname><given-names>C. C.</given-names></name>; <name><surname>Cowtan</surname><given-names>K. D.</given-names></name>; <name><surname>Dodson</surname><given-names>E. J.</given-names></name>; <name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Evans</surname><given-names>P. R.</given-names></name>; <name><surname>Keegan</surname><given-names>R. M.</given-names></name>; <name><surname>Krissinel</surname><given-names>E. B.</given-names></name>; <name><surname>Leslie</surname><given-names>A. G.</given-names></name>; <name><surname>McCoy</surname><given-names>A.</given-names></name>; <name><surname>McNicholas</surname><given-names>S. J.</given-names></name>; <name><surname>Murshudov</surname><given-names>G. N.</given-names></name>; <name><surname>Pannu</surname><given-names>N. S.</given-names></name>; <name><surname>Potterton</surname><given-names>E. A.</given-names></name>; <name><surname>Powell</surname><given-names>H. R.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>; <name><surname>Vagin</surname><given-names>A.</given-names></name>; <name><surname>Wilson</surname><given-names>K. S.</given-names></name> (<year>2011</year>) <article-title>Overview of the CCP4 suite and current developments</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>67</volume>, <fpage>235</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444910045749</pub-id>.<pub-id pub-id-type="pmid">21460441</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Potterton</surname><given-names>L.</given-names></name>; <name><surname>Agirre</surname><given-names>J.</given-names></name>; <name><surname>Ballard</surname><given-names>C.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name>; <name><surname>Dodson</surname><given-names>E.</given-names></name>; <name><surname>Evans</surname><given-names>P. R.</given-names></name>; <name><surname>Jenkins</surname><given-names>H. T.</given-names></name>; <name><surname>Keegan</surname><given-names>R.</given-names></name>; <name><surname>Krissinel</surname><given-names>E.</given-names></name>; <name><surname>Stevenson</surname><given-names>K.</given-names></name>; <name><surname>Lebedev</surname><given-names>A.</given-names></name>; <name><surname>McNicholas</surname><given-names>S. J.</given-names></name>; <name><surname>Nicholls</surname><given-names>R. A.</given-names></name>; <name><surname>Noble</surname><given-names>M.</given-names></name>; <name><surname>Pannu</surname><given-names>N. S.</given-names></name>; <name><surname>Roth</surname><given-names>C.</given-names></name>; <name><surname>Sheldrick</surname><given-names>G.</given-names></name>; <name><surname>Skubak</surname><given-names>P.</given-names></name>; <name><surname>Turkenburg</surname><given-names>J.</given-names></name>; <name><surname>Uski</surname><given-names>V.</given-names></name>; <name><surname>von Delft</surname><given-names>F.</given-names></name>; <name><surname>Waterman</surname><given-names>D.</given-names></name>; <name><surname>Wilson</surname><given-names>K.</given-names></name>; <name><surname>Winn</surname><given-names>M.</given-names></name>; <name><surname>Wojdyr</surname><given-names>M.</given-names></name> (<year>2018</year>) <article-title>CCP4i2: the new graphical user interface to the CCP4 program
suite</article-title>. <source>Acta Crystallogr D Struct Biol</source>
<volume>74</volume>, <fpage>68</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1107/S2059798317016035</pub-id>.<pub-id pub-id-type="pmid">29533233</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Evans</surname><given-names>P. R.</given-names></name>; <name><surname>Murshudov</surname><given-names>G. N.</given-names></name> (<year>2013</year>) <article-title>How good are my data and what is the resolution</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>69</volume>, <fpage>1204</fpage>&#x02013;<lpage>1214</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444913000061</pub-id>.<pub-id pub-id-type="pmid">23793146</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Evans</surname><given-names>P.</given-names></name> (<year>2006</year>) <article-title>Scaling and assessment of data quality</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>62</volume>, <fpage>72</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444905036693</pub-id>.<pub-id pub-id-type="pmid">16369096</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Evans</surname><given-names>P. R.</given-names></name> (<year>2011</year>) <article-title>An introduction to data reduction: space-group determination, scaling and
intensity statistics</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>67</volume>, <fpage>282</fpage>&#x02013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1107/S090744491003982X</pub-id>.<pub-id pub-id-type="pmid">21460446</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name>; <name><surname>Winn</surname><given-names>M. D.</given-names></name>; <name><surname>Storoni</surname><given-names>L. C.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name> (<year>2007</year>) <article-title>Phaser crystallographic software</article-title>. <source>J. Appl. Crystallogr.</source>
<volume>40</volume>, <fpage>658</fpage>&#x02013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id>.<pub-id pub-id-type="pmid">19461840</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Lohkamp</surname><given-names>B.</given-names></name>; <name><surname>Scott</surname><given-names>W. G.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name> (<year>2010</year>) <article-title>Features and development of Coot</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>66</volume>, <fpage>486</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Liebschner</surname><given-names>D.</given-names></name>; <name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Baker</surname><given-names>M. L.</given-names></name>; <name><surname>Bunk&#x000f3;czi</surname><given-names>G.</given-names></name>; <name><surname>Chen</surname><given-names>V. B.</given-names></name>; <name><surname>Croll</surname><given-names>T. I.</given-names></name>; <name><surname>Hintze</surname><given-names>B.</given-names></name>; <name><surname>Hung</surname><given-names>L. W.</given-names></name>; <name><surname>Jain</surname><given-names>S.</given-names></name>; <name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>; <name><surname>Oeffner</surname><given-names>R. D.</given-names></name>; <name><surname>Poon</surname><given-names>B. K.</given-names></name>; <name><surname>Prisant</surname><given-names>M. G.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>; <name><surname>Richardson</surname><given-names>J. S.</given-names></name>; <name><surname>Richardson</surname><given-names>D. C.</given-names></name>; <name><surname>Sammito</surname><given-names>M. D.</given-names></name>; <name><surname>Sobolev</surname><given-names>O. V.</given-names></name>; <name><surname>Stockwell</surname><given-names>D. H.</given-names></name>; <name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Urzhumtsev</surname><given-names>A. G.</given-names></name>; <name><surname>Videau</surname><given-names>L. L.</given-names></name>; <name><surname>Williams</surname><given-names>C. J.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name> (<year>2019</year>) <article-title>Macromolecular structure determination using X-rays, neutrons and
electrons: recent developments in Phenix</article-title>. <source>Acta Crystallogr D Struct Biol</source>
<volume>75</volume>, <fpage>861</fpage>&#x02013;<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1107/S2059798319011471</pub-id>.<pub-id pub-id-type="pmid">31588918</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>Echols</surname><given-names>N.</given-names></name>; <name><surname>Headd</surname><given-names>J. J.</given-names></name>; <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>; <name><surname>Mustyakimov</surname><given-names>M.</given-names></name>; <name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Urzhumtsev</surname><given-names>A.</given-names></name>; <name><surname>Zwart</surname><given-names>P. H.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name> (<year>2012</year>) <article-title>Towards automated crystallographic structure refinement with
phenix.refine</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>68</volume>, <fpage>352</fpage>&#x02013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444912001308</pub-id>.<pub-id pub-id-type="pmid">22505256</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Lei</surname><given-names>J.</given-names></name>; <name><surname>Kusov</surname><given-names>Y.</given-names></name>; <name><surname>Hilgenfeld</surname><given-names>R.</given-names></name> (<year>2018</year>) <article-title>Nsp3 of coronaviruses: Structures and functions of a large multi-domain
protein</article-title>. <source>Antiviral Res.</source>
<volume>149</volume>, <fpage>58</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.11.001</pub-id>.<pub-id pub-id-type="pmid">29128390</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Leung</surname><given-names>A. K. L.</given-names></name>; <name><surname>McPherson</surname><given-names>R. L.</given-names></name>; <name><surname>Griffin</surname><given-names>D. E.</given-names></name> (<year>2018</year>) <article-title>Macrodomain ADP-ribosylhydrolase and the pathogenesis of infectious
diseases</article-title>. <source>PLoS Pathog.</source>
<volume>14</volume>, <elocation-id>e1006864</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006864</pub-id>.<pub-id pub-id-type="pmid">29566066</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Almeida</surname><given-names>M. S.</given-names></name>; <name><surname>Johnson</surname><given-names>M. A.</given-names></name>; <name><surname>Herrmann</surname><given-names>T.</given-names></name>; <name><surname>Geralt</surname><given-names>M.</given-names></name>; <name><surname>W&#x000fc;thrich</surname><given-names>K.</given-names></name> (<year>2007</year>) <article-title>Novel beta-barrel fold in the nuclear magnetic resonance structure of the
replicase nonstructural protein 1 from the severe acute respiratory syndrome
coronavirus</article-title>. <source>J. Virol.</source>
<volume>81</volume>, <fpage>3151</fpage>&#x02013;<lpage>3161</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01939-06</pub-id>.<pub-id pub-id-type="pmid">17202208</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Johnson</surname><given-names>M. A.</given-names></name>; <name><surname>Chatterjee</surname><given-names>A.</given-names></name>; <name><surname>Neuman</surname><given-names>B. W.</given-names></name>; <name><surname>W&#x000fc;thrich</surname><given-names>K.</given-names></name> (<year>2010</year>) <article-title>SARS coronavirus unique domain: three-domain molecular architecture in
solution and RNA binding</article-title>. <source>J. Mol. Biol.</source>
<volume>400</volume>, <fpage>724</fpage>&#x02013;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2010.05.027</pub-id>.<pub-id pub-id-type="pmid">20493876</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>B&#x000e1;ez-Santos</surname><given-names>Y. M.</given-names></name>; <name><surname>Barraza</surname><given-names>S. J.</given-names></name>; <name><surname>Wilson</surname><given-names>M. W.</given-names></name>; <name><surname>Agius</surname><given-names>M. P.</given-names></name>; <name><surname>Mielech</surname><given-names>A. M.</given-names></name>; <name><surname>Davis</surname><given-names>N. M.</given-names></name>; <name><surname>Baker</surname><given-names>S. C.</given-names></name>; <name><surname>Larsen</surname><given-names>S. D.</given-names></name>; <name><surname>Mesecar</surname><given-names>A. D.</given-names></name> (<year>2014</year>) <article-title>X-ray structural and biological evaluation of a series of potent and highly
selective inhibitors of human coronavirus papain-like proteases</article-title>. <source>J. Med. Chem.</source>
<volume>57</volume>, <fpage>2393</fpage>&#x02013;<lpage>2412</lpage>. <pub-id pub-id-type="doi">10.1021/jm401712t</pub-id>.<pub-id pub-id-type="pmid">24568342</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Serrano</surname><given-names>P.</given-names></name>; <name><surname>Johnson</surname><given-names>M. A.</given-names></name>; <name><surname>Chatterjee</surname><given-names>A.</given-names></name>; <name><surname>Neuman</surname><given-names>B. W.</given-names></name>; <name><surname>Joseph</surname><given-names>J. S.</given-names></name>; <name><surname>Buchmeier</surname><given-names>M. J.</given-names></name>; <name><surname>Kuhn</surname><given-names>P.</given-names></name>; <name><surname>W&#x000fc;thrich</surname><given-names>K.</given-names></name> (<year>2009</year>) <article-title>Nuclear magnetic resonance structure of the nucleic acid-binding domain of
severe acute respiratory syndrome coronavirus nonstructural protein 3</article-title>. <source>J. Virol.</source>
<volume>83</volume>, <fpage>12998</fpage>&#x02013;<lpage>13008</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01253-09</pub-id>.<pub-id pub-id-type="pmid">19828617</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Akaji</surname><given-names>K.</given-names></name>; <name><surname>Konno</surname><given-names>H.</given-names></name>; <name><surname>Mitsui</surname><given-names>H.</given-names></name>; <name><surname>Teruya</surname><given-names>K.</given-names></name>; <name><surname>Shimamoto</surname><given-names>Y.</given-names></name>; <name><surname>Hattori</surname><given-names>Y.</given-names></name>; <name><surname>Ozaki</surname><given-names>T.</given-names></name>; <name><surname>Kusunoki</surname><given-names>M.</given-names></name>; <name><surname>Sanjoh</surname><given-names>A.</given-names></name> (<year>2011</year>) <article-title>Structure-based design, synthesis, and evaluation of peptide-mimetic SARS
3CL protease inhibitors</article-title>. <source>J. Med. Chem.</source>
<volume>54</volume>, <fpage>7962</fpage>&#x02013;<lpage>7973</lpage>. <pub-id pub-id-type="doi">10.1021/jm200870n</pub-id>.<pub-id pub-id-type="pmid">22014094</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Kirchdoerfer</surname><given-names>R. N.</given-names></name>; <name><surname>Ward</surname><given-names>A. B.</given-names></name> (<year>2019</year>) <article-title>Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8
co-factors</article-title>. <source>Nat. Commun.</source>
<volume>10</volume>, <fpage>2342</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-10280-3</pub-id>.<pub-id pub-id-type="pmid">31138817</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Egloff</surname><given-names>M. P.</given-names></name>; <name><surname>Ferron</surname><given-names>F.</given-names></name>; <name><surname>Campanacci</surname><given-names>V.</given-names></name>; <name><surname>Longhi</surname><given-names>S.</given-names></name>; <name><surname>Rancurel</surname><given-names>C.</given-names></name>; <name><surname>Dutartre</surname><given-names>H.</given-names></name>; <name><surname>Snijder</surname><given-names>E. J.</given-names></name>; <name><surname>Gorbalenya</surname><given-names>A. E.</given-names></name>; <name><surname>Cambillau</surname><given-names>C.</given-names></name>; <name><surname>Canard</surname><given-names>B.</given-names></name> (<year>2004</year>) <article-title>The severe acute respiratory syndrome-coronavirus replicative protein nsp9
is a single-stranded RNA-binding subunit unique in the RNA virus world</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>101</volume>, <fpage>3792</fpage>&#x02013;<lpage>3796</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0307877101</pub-id>.<pub-id pub-id-type="pmid">15007178</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Ma</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>L.</given-names></name>; <name><surname>Shaw</surname><given-names>N.</given-names></name>; <name><surname>Gao</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Lou</surname><given-names>Z.</given-names></name>; <name><surname>Yan</surname><given-names>L.</given-names></name>; <name><surname>Zhang</surname><given-names>R.</given-names></name>; <name><surname>Rao</surname><given-names>Z.</given-names></name> (<year>2015</year>) <article-title>Structural basis and functional analysis of the SARS coronavirus
nsp14-nsp10 complex</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>112</volume>, <fpage>9436</fpage>&#x02013;<lpage>9441</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1508686112</pub-id>.<pub-id pub-id-type="pmid">26159422</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Jia</surname><given-names>Z.</given-names></name>; <name><surname>Yan</surname><given-names>L.</given-names></name>; <name><surname>Ren</surname><given-names>Z.</given-names></name>; <name><surname>Wu</surname><given-names>L.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Guo</surname><given-names>J.</given-names></name>; <name><surname>Zheng</surname><given-names>L.</given-names></name>; <name><surname>Ming</surname><given-names>Z.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Lou</surname><given-names>Z.</given-names></name>; <name><surname>Rao</surname><given-names>Z.</given-names></name> (<year>2019</year>) <article-title>Delicate structural coordination of the Severe Acute Respiratory Syndrome
coronavirus Nsp13 upon ATP hydrolysis</article-title>. <source>Nucleic Acids Res.</source>
<volume>47</volume>, <fpage>6538</fpage>&#x02013;<lpage>6550</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz409</pub-id>.<pub-id pub-id-type="pmid">31131400</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Ricagno</surname><given-names>S.</given-names></name>; <name><surname>Egloff</surname><given-names>M. P.</given-names></name>; <name><surname>Ulferts</surname><given-names>R.</given-names></name>; <name><surname>Coutard</surname><given-names>B.</given-names></name>; <name><surname>Nurizzo</surname><given-names>D.</given-names></name>; <name><surname>Campanacci</surname><given-names>V.</given-names></name>; <name><surname>Cambillau</surname><given-names>C.</given-names></name>; <name><surname>Ziebuhr</surname><given-names>J.</given-names></name>; <name><surname>Canard</surname><given-names>B.</given-names></name> (<year>2006</year>) <article-title>Crystal structure and mechanistic determinants of SARS coronavirus
nonstructural protein 15 define an endoribonuclease family</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>103</volume>, <fpage>11892</fpage>&#x02013;<lpage>11897</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0601708103</pub-id>.<pub-id pub-id-type="pmid">16882730</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Decroly</surname><given-names>E.</given-names></name>; <name><surname>Debarnot</surname><given-names>C.</given-names></name>; <name><surname>Ferron</surname><given-names>F.</given-names></name>; <name><surname>Bouvet</surname><given-names>M.</given-names></name>; <name><surname>Coutard</surname><given-names>B.</given-names></name>; <name><surname>Imbert</surname><given-names>I.</given-names></name>; <name><surname>Gluais</surname><given-names>L.</given-names></name>; <name><surname>Papageorgiou</surname><given-names>N.</given-names></name>; <name><surname>Sharff</surname><given-names>A.</given-names></name>; <name><surname>Bricogne</surname><given-names>G.</given-names></name>; <name><surname>Ortiz-Lombardia</surname><given-names>M.</given-names></name>; <name><surname>Lescar</surname><given-names>J.</given-names></name>; <name><surname>Canard</surname><given-names>B.</given-names></name> (<year>2011</year>) <article-title>Crystal structure and functional analysis of the SARS-coronavirus RNA cap
2&#x02019;-O-methyltransferase nsp10/nsp16 complex</article-title>. <source>PLoS Pathog.</source>
<volume>7</volume>, <elocation-id>e1002059</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002059</pub-id>.<pub-id pub-id-type="pmid">21637813</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Cho</surname><given-names>C. C.</given-names></name>; <name><surname>Lin</surname><given-names>M. H.</given-names></name>; <name><surname>Chuang</surname><given-names>C. Y.</given-names></name>; <name><surname>Hsu</surname><given-names>C. H.</given-names></name> (<year>2016</year>) <article-title>Macro Domain from Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Is an Efficient ADP-ribose Binding Module: CRYSTAL STRUCTURE AND BIOCHEMICAL
STUDIES</article-title>. <source>J. Biol. Chem.</source>
<volume>291</volume>, <fpage>4894</fpage>&#x02013;<lpage>4902</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.700542</pub-id>.<pub-id pub-id-type="pmid">26740631</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Pettersen</surname><given-names>E. F.</given-names></name>; <name><surname>Goddard</surname><given-names>T. D.</given-names></name>; <name><surname>Huang</surname><given-names>C. C.</given-names></name>; <name><surname>Couch</surname><given-names>G. S.</given-names></name>; <name><surname>Greenblatt</surname><given-names>D. M.</given-names></name>; <name><surname>Meng</surname><given-names>E. C.</given-names></name>; <name><surname>Ferrin</surname><given-names>T. E.</given-names></name> (<year>2004</year>) <article-title>UCSF Chimera--a visualization system for exploratory research and
analysis</article-title>. <source>J. Comput. Chem.</source>
<volume>25</volume>, <fpage>1605</fpage>&#x02013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id>.<pub-id pub-id-type="pmid">15264254</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Cong</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Wei</surname><given-names>L.</given-names></name>; <name><surname>Zhao</surname><given-names>Q.</given-names></name>; <name><surname>Xu</surname><given-names>X.</given-names></name>; <name><surname>Ma</surname><given-names>Y.</given-names></name>; <name><surname>Bartlam</surname><given-names>M.</given-names></name>; <name><surname>Rao</surname><given-names>Z.</given-names></name> (<year>2009</year>) <article-title>Crystal structures of two coronavirus
ADP-ribose-1&#x02019;&#x02019;-monophosphatases and their complexes with ADP-Ribose: a
systematic structural analysis of the viral ADRP domain</article-title>. <source>J. Virol.</source>
<volume>83</volume>, <fpage>1083</fpage>&#x02013;<lpage>1092</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01862-08</pub-id>.<pub-id pub-id-type="pmid">18987156</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Wojdyla</surname><given-names>J. A.</given-names></name>; <name><surname>Manolaridis</surname><given-names>I.</given-names></name>; <name><surname>Snijder</surname><given-names>E. J.</given-names></name>; <name><surname>Gorbalenya</surname><given-names>A. E.</given-names></name>; <name><surname>Coutard</surname><given-names>B.</given-names></name>; <name><surname>Piotrowski</surname><given-names>Y.</given-names></name>; <name><surname>Hilgenfeld</surname><given-names>R.</given-names></name>; <name><surname>Tucker</surname><given-names>P. A.</given-names></name> (<year>2009</year>) <article-title>Structure of the X (ADRP) domain of nsp3 from feline
coronavirus</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>65</volume>, <fpage>1292</fpage>&#x02013;<lpage>1300</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444909040074</pub-id>.<pub-id pub-id-type="pmid">19966415</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Krissinel</surname><given-names>E.</given-names></name>; <name><surname>Henrick</surname><given-names>K.</given-names></name> (<year>2004</year>) <article-title>Secondary-structure matching (SSM), a new tool for fast protein structure
alignment in three dimensions</article-title>. <source>Acta Crystallogr., Sect. D: Biol. Crystallogr.</source>
<volume>60</volume>, <fpage>2256</fpage>&#x02013;<lpage>2268</lpage>. <pub-id pub-id-type="doi">10.1107/S0907444904026460</pub-id>.<pub-id pub-id-type="pmid">15572779</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Keep</surname><given-names>S.</given-names></name>; <name><surname>Bickerton</surname><given-names>E.</given-names></name>; <name><surname>Armesto</surname><given-names>M.</given-names></name>; <name><surname>Britton</surname><given-names>P.</given-names></name> (<year>2018</year>) <article-title>The ADRP domain from a virulent strain of infectious bronchitis virus is
not sufficient to confer a pathogenic phenotype to the attenuated Beaudette
strain</article-title>. <source>J. Gen. Virol.</source>
<volume>99</volume>, <fpage>1097</fpage>&#x02013;<lpage>1102</lpage>. <pub-id pub-id-type="doi">10.1099/jgv.0.001098</pub-id>.<pub-id pub-id-type="pmid">29893665</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Abraham</surname><given-names>R.</given-names></name>; <name><surname>McPherson</surname><given-names>R. L.</given-names></name>; <name><surname>Dasovich</surname><given-names>M.</given-names></name>; <name><surname>Badiee</surname><given-names>M.</given-names></name>; <name><surname>Leung</surname><given-names>A. K. L.</given-names></name>; <name><surname>Griffin</surname><given-names>D. E.</given-names></name> (<year>2020</year>) <article-title>Both ADP-Ribosyl-Binding and Hydrolase Activities of the Alphavirus nsP3
Macrodomain Affect Neurovirulence in Mice</article-title>. <source>mBio</source>
<volume>11</volume>, <elocation-id>e03253-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.03253-19</pub-id>.<pub-id pub-id-type="pmid">32047134</pub-id></mixed-citation></ref></ref-list></back></article>